Member Info for travel_light

Half listened to the webinar yesterday.

DV working with aptamer group and a small mass spec machine.

Be interesting to ask why Avacta not involved, maybe they are but have enough fingers in the pie not to need more speculation in news. Maybe the license being negotiated for bams is exclusive.

Don’t know enough about the topic, and also half asleep. But also something different from the other RNS.

Ahhh as if by magic it fixed. Wtf?

Odd this change, who would have thought having a president who is willing to listen to science rather than Fox would make a difference. Wow

Are some posts missing from this thread. Says 7 but can only see 4???

Lse forum tech, it’s a world of its own

diagnostics....

prove it works, prove it can be made, license, the heavy lifting is global sales. avacta hasn't got a global sales team.

agentB,

affimer could grab biological marker molecules, they are then analysed in a mass spec machine. Deep verge AI figures out the tune from the noise.

nice innovation, wonder if IP can be protected. In a few years time a medical would be cough twice, pee in this pot, breath in this tube. You are good to go. Give it a few more year and Bones will have a little hand held swirly thing he runs over your body. Seriously, if it works, it could change diagnostics and catch things early. Be cool of affimers are the capture solution.

glad to see the potential is caught the markets eye.....errrr red number ????

bump, it made me laugh

Bugger my spell check, hope it raises a smile

I suspect Gerry would love UK contract but looks at the team in charge and figures there only so much you can do.

But that the UK is talking about it means it’s likely similar stories across the world (France, Italy, Indonesia,Costa Rica, St Kits). Adds another piece to a large jigsaw. why such a negative reaction to a post which adds to the bugger picture.

more likely that, as was said in video, the quality and consistency of a batch for something on a sniffle stick is different from that for something you inject in you.

I think drugs are manufactured under stricter controls than medical devices, and hence Avacta uses third party expertise. Great, it's a commodity value, why spend money developing that capability, until it hit meaningful volumes. The value is in the IPR not the machines making tablets. Not an expert, just a feeling.

?

To be fair you have a point, but the worth the investment or not depends on risk tolerance. Would I bet the house.... no. Enough to hurt but a win will change my retirement plans.....yes.

The critism has foundation, but realistically other companies take as long. So yeah cut the PR speel
and stick to facts.

Avacta and to some extent AIM is like public VC calls. High risk, high gain. The main market has sold me lower risk, more mature/experienced stocks/ceos

VC not unusual to provide stock options for workers who are likely working their nads off to realize your investment.

search vox paul hill, and goto home page

Why doesn’t he buy shares? No cash or not allowed?

more likely the usage is spun off. Avacta don't have a global sales and distribution line, so the value is in the license rather than the "business".

I doubt the company per se would be split.

good find, thanks

also wants it hit a certain market cap, some new players enter. That should hopefully also mean some upward pressure.

The revenue for Covid, awesome, but then think about the use of antibodies in diagnostics. They are difficult to produce, hard to handle, big etc etc. Covid is baptism of fire but also means a huge reference case for other conditions. That medium and long term story is a strong force. 1 year windfall revenue nice, might be longer, but a new tool for a huge list of diagnostics tests will attract bigger fish.

https://www.bbc.com/news/health-56358257

Interesting thread. Thanks all.

Whilst the opportunity isn’t concrete, nice to see the scope of opportunity. Takes bandwidth thou and expertise.

Maybe TT requires supply chain to be secured and is waiting for QA certification. Mologic somehow can make ce marked tests without Avacta having a cert.

Have to admit I have no idea how it works in pharm.

anyone have any idea. Could Mologic make own Affimers under own cert with Avacta permission?

Just wild guesses in my part, but interesting TT not complete.

Interesting, thanks for posting